Like BioBright LLC

announced 6/26/2020 via BusinessWire

Dotmatics, will acquire BioBright LLC

synopsis: UK-based Dotmatics Ltd., a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery, and innovation research, will acquire BioBright LLC, a leader in automating the flow of data from laboratory instruments to a secure cloud.
buyer parent: Scottish Equity Partners
buyer: Dotmatics
UK-based Dotmatics is a scientific informatics software and services company that is driving the automation of laboratory workflows for discovery and innovation research—accelerating the journey towards full digitalization and the Lab of the Future. "
target: BioBright LLC
BioBright's mission is to revolutionize the way biological research is done by building tools that augment the scientist. The company's DarwinSync platform automatically uploads scientific data from any instrument and makes it available for search, analysis, and discovery.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/14/2019 via PR Newswire

Bruker Corporation, acquired Arxspan

synopsis: Bruker Corporation announced that it has acquired Arxspan LLC, a provider of cloud-based scientific software and workflow solutions. Arxspan is known for its line of cloud-based products for the management of research data under the Arxlab®brand. The company has a focus on serving pharmaceutical and biopharma customers.
buyer: Bruker Corporation (BRKR:$1,925.30)
Bruker provides the best technological solution for each analytical task. Bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability. "
target: Arxspan
Arxspan provides cloud-based solutions to meet the scientific data management needs of leading life sciences, chemicals, and scientific companies. Arxspan offers ArxLab, a suite of web-based scientific informatics applications, allowing scientists to record, manage, and share their research data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/13/2017 via PR Newswire

SciBite, acquired FactBio Ltd

synopsis: SciBite, a firm whose technology is revolutionising R&D for pharmaceutical companies across the globe, has acquired Cambridge based FactBio, a leading developer of semantic software for data management and curation for the life sciences.
buyer: SciBite
SciBite offer a complete semantic services platform for life sciences that can be used as a data analytics solution by end users and also as a 'pluggable' component to transform existing IT infrastructures into more scientifically aware systems. "
target: FactBio Ltd
FactBio is a leading developer of semantic software for data management and curation for the life sciences. FactBio builds ontologies and tools for the curation and management of scientific data. The company's focus is on biomedical data, with the potential to apply its tools more widely.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/9/2019 via BNC Analysis

RJ Capital Partners, acquired Infonetica ltd.

synopsis: RJ Capital Partners, a UK-based entrepreneurial firm, has acquired Infonetica, a global provider of intuitive software solutions, serving national health trusts, internationally renowned universities and governments. Infonetica offers solutions for research management, ethics application approval, tissue sample tracking, and compliance training.
buyer: RJ Capital Partners
RJ Capital Partners is a UK-based entrepreneurial firm set up to acquire, actively manage and grow one privately-held business that has the potential to become a leader in its industry. RJ Capital Partners was established by Raja Prasanna, a highly experienced entrepreneur. "
target: Infonetica ltd.
Infonetica is a global provider of intuitive software solutions, serving national health trusts, internationally renowned universities and governments. Infonetica offers solutions for research management, ethics application approval, tissue sample tracking, and compliance training.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/13/2019 via BNC Analysis

IQVIA, acquired Linguamatics Limited

synopsis: Health analytics and contract research heavyweight IQvia has acquired bioinformatics company Linguamatics. Linguamatics delivers market-leading Natural Language Processing (NLP) based AI solutions for high-value knowledge discovery and decision support from text.
buyer: IQVIA (NYSE:IQV:$10,412.00)
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. "
target: Linguamatics Limited
Linguamatics delivers market-leading Natural Language Processing (NLP) based AI solutions for high-value knowledge discovery and decision support from text. They empower their customers to speed up drug development and improve patient outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/29/2016 via Company Press Release

MedStreaming, LLC, acquired M2S

synopsis: Medstreaming, a leading provider of innovative healthcare cardiovascular and radiology workflow software solutions, announced the acquisition of M2S, a leading provider of registry software technology designed for healthcare quality improvement.
buyer: MedStreaming, LLC
Medstreaming is a provider of innovative healthcare cardiovascular and radiology workflow software solutions. Since 2006, Medstreaming has become a leader in delivering specialty-based workflow applications that function as a “best of breed” application for over 20 different clinical specialties. "
target parent: Altaris Capital Partners
target: M2S
M2S, Inc. provides medical image, data management, and and outcomes analysis services for the improvement of patient outcomes. It offers image management solutions to allow customers to collect, view, and manage imaging data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/13/2012 via BusinessWire

athenahealth, Inc., will acquire Healthcare Data Services LLC

synopsis: athenahealth, Inc., a leading provider of cloud-based practice management, electronic health record, and care coordination services, has signed a definitive agreement to acquire Healthcare Data Services LLC, a web-based solutions provider and expert in health care data analysis and population health management for payers and providers.
buyer: athenahealth, Inc. (ATHN:$1,311.40)
athenahealth, Inc. is a leading provider of cloud-based business services for physician practices. athenahealth’s service offerings are based on proprietary web-native practice management and electronic health record software. "
target: Healthcare Data Services LLC
Healthcare Data Services LLC is a web-based solutions provider and expert in health care data analysis and population health management for payers and providers. Healthcare Data Services provides a highly customizable approach to integrated health care data analysis.
price ($mm)
$5.80
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/8/2020 via Company Press Release

Phlexglobal, acquired Cunesoft

synopsis: Phlexglobal, the leading provider of Trial Master File (TMF) software and expert services, has acquired Cunesoft, a European leader in cloud-based regulatory software solutions for the life sciences industry. Cunesoft offers a machine learning powered regulatory compliance software suite for compliant document, data and submission management.
buyer parent: Vitruvian Partners LLP
buyer: Phlexglobal
Phlexglobal is the world-leading specialist provider of electronic Trial Master File (eTMF) systems and services to the life sciences industry. Phlexglobal leverages authoritative TMF technologies and expert services to bring order, stability, and control to their client's Trial Master File. "
target: Cunesoft
Cunesoft is a European leader in cloud-based regulatory software solutions and services for all segments within the life sciences industry. Cunesoft offers a machine learning powered regulatory compliance software suite for compliant document, data and submission management.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2018 via BusinessWire

Anju Software, acquired Zephyr Health

synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, announced that it has acquired San Francisco-based Zephyr Health, a company that provides comprehensive physician, institution and treatment data for every major disease area.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions. Anju was founded by professionals with deep software domain expertise and a track record of building software platforms through strategic acquisitions and organic growth. "
target: Zephyr Health
Founded in 2011, Zephyr Health is the leading insights-as-a-service company harnessing the power of global healthcare data for precise and confident product lifecycle performance for biopharmaceutical and medical device companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/29/2012 via PR Newswire

Deloitte Consulting, acquired Recombinant Data Corp.

synopsis: Deloitte announced the acquisition of Recombinant Data Corp., a fast-growing provider of data warehousing and clinical intelligence solutions that enable advances in personalized medicine, translational research and health-care performance management.
buyer parent: Deloitte LLP
buyer: Deloitte Consulting
Deloitte Consulting is the world's largest management consulting firm, and is uniquely known for its straightforward approach to solving today's most complex business challenges. Deloitte Consultants work hand-in-hand with clients to improve business performance. "
target: Recombinant Data Corp.
Recombinant offers health-care providers and academic medical centers proven, leading-edge data warehousing and clinical intelligence solutions to deliver higher quality outcomes, accelerate personalized medicine, and lower costs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2017 via BusinessWire

Thermo Fisher Scientific, Inc., acquired Core Informatics LLC

synopsis: Thermo Fisher Scientific Inc. announced that it has acquired Core Informatics, which provides a cloud-based platform supporting scientific data management. Core’s offerings will enhance Thermo Fisher’s existing informatics solutions and complement its cloud platform, which supports the company’s genetic analysis, qPCR and proteomics systems.
buyer: Thermo Fisher Scientific, Inc. (TMO:$24,630.00)
Thermo Fisher Scientific Inc. offers an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. They help customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. "
target: Core Informatics LLC
Core Informatics partners with customers in biopharma, genomics, and other industries to deliver lab informatics solutions to derive more value and insight from scientific data. Core Informatics provides the scalable Platform for Science that enables customers to build workflows for specific needs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/23/2010 via BusinessWire

IMI Health, Inc., acquired BoundaryMedical, Inc.

synopsis: IMI Health (IMI), a health care information company, has acquired Minneapolis-based BoundaryMedical, a leading outcomes measurement software company. Boundary’s Outcome Enterprise™ software complements IMI’s health care business intelligence tools giving both companies’ customers more robust data collection and analysis.
buyer: IMI Health, Inc.
Founded in 1995, IMI Health has evolved from being predominately a healthcare data and Business Intelligence platform provider into a healthcare data solutions company. In 2008 the company was listed on INC Magazine’s 5000 fastest growing companies. "
target: BoundaryMedical, Inc.
BoundaryMedical, Inc. is a leading provider of SaaS-based outcome measurement solutions through its Outcome Enterprise™ platform. BoundaryMedical offers an affordable and easy-to-use tool for outcome measurement projects including studies, registries or routine P4P and CER measurement projects.
price ($mm)
rev ($mm)
$1
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 11/17/2008 via PR Newswire

Clinsys Clinical Research, Inc., purchased ClinicalAnalytics(R) from TrialStat Corporation

synopsis: Jubilant Organosys Ltd. announced that its subsidiary Clinsys Clinical Research, Inc.(R), New Jersey, a global contract research organization (CRO), has acquired TrialStat ClinicalAnalytics(R) from TrialStat(R) for a purchase consideration of CAD 750,000.
buyer parent: Jubilant Organosys Ltd.
buyer: Clinsys Clinical Research, Inc.
Clinsys Clinical Research, Inc.®, a Jubilant Organosys company, is a therapeutically focused clinical research organization. We provide pharmaceutical, biotechnology and medical device companies with a broad range of clinical research services. "
seller: TrialStat Corporation
TrialStat is a technology and services company providing powerful, cost-effective turn-key data capture and management tools for researchers and investigators in health care. TrialStat provides industrial strength data management software solutions to the clinical research community.
price ($mm)
$0.62
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/10/2019 via PR Newswire

Healthaxis, Inc., acquired Analytics Partners

synopsis: HealthAxis Group announced the acquisition of Analytics Partners based in Jacksonville, FL. Analytics Partners specializes in analytics solutions such as historical trend analysis, risk assessments, fraud indicators and claims reporting for Healthcare organizations.
buyer: Healthaxis, Inc. (HAXS:$0.00)
HealthAxis Group is simultaneously the most experienced and modern SaaS-based supplier of benefit platform systems. The comprehensive suite offered by HealthAxis helps organizations address compliance, increase administrative efficiency, lower cost, and improve quality. "
target: Analytics Partners
Analytics Partners specializes in analytics solutions such as historical trend analysis, risk assessments, fraud indicators and claims reporting for Healthcare organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/31/2017 via Company Press Release

Summa Equity, acquired Ivbar

synopsis: Summa Equity has acquired IVBAR Institute AB. IVBAR is a Swedish digital health company that has developed a big data analytics platform, ERA Vision, that enables improved management of healthcare through a focus on patient value.
buyer: Summa Equity
Summa Equity was formed in 2016 by partners with a shared vision of building a leading specialised private equity firm in the Nordic lower mid-market, positioned to capture the investment opportunity provided by the thematic megatrends expected to drive growth over the long term. "
target: Ivbar
IVBAR is a Swedish digital health company that has developed a big data analytics platform, ERA Vision, that enables improved management of healthcare through a focus on patient value.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/20/2017 via PR Newswire

Change Healthcare Corporation, acquired Docufill, LLC

synopsis: Change Healthcare has acquired Docufill, LLC, a cloud-based technology that allows providers to use a single shared form across the organization to streamline the otherwise administratively complex and redundant credentialing process.
buyer parent: McKesson Corporation
buyer: Change Healthcare Corporation (CHNG:$0.00)
Change Healthcare is inspiring a better healthcare system. They leverage their software and analytics, network solutions, and technology-enabled services to help them improve efficiency, reduce costs, increase cash flow, and more effectively manage complex workflows. "
target: Docufill, LLC
Docufill, LLC is a cloud-based technology that allows providers to use a single shared form across the organization to streamline the otherwise administratively complex and redundant credentialing process.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/18/2018 via PR Newswire

Quest Analytics, L.L.C., acquired BetterDoctor, Inc.

synopsis: Quest Analytics, the leading provider of network access and adequacy services to health plans and insurance regulatory agencies, announced that it has acquired BetterDoctor, the nation's most accurate provider data management platform.
buyer parent: Vestar Capital Partners
buyer: Quest Analytics, L.L.C.
Quest Analytics is the first comprehensive platform that enables health plans to optimize their member experience, while complying with federal and state regulations for network adequacy and accuracy. "
target: BetterDoctor, Inc.
BetterDoctor is an engine that powers the healthcare market with accurate provider data. BetterDoctor helps validate and deliver accurate provider data to health plans, health systems, and hundreds of other companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/10/2018 via PR Newswire

Elsevier B.V., acquired Aries Systems Corp.

synopsis: Elsevier, the global information analytics business specializing in science and health, announced it has acquired Aries Systems, a leader in scientific publication workflow solutions headquartered outside Boston, MA. Aries' offerings are used for manuscript submission, peer review, production tracking and eCommerce.
buyer parent: RELX Group plc
buyer: Elsevier B.V.
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions in the areas of strategic research management, R&D performance, and more. "
target: Aries Systems Corp.
Aries Systems transforms the way scholarly publishers bring high-value content to the world. The company’s innovative and forward-looking workflow solutions manage the complexities of modern print and electronic publishing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/15/2015 via Market Wire

Pethealth Inc., acquired HumaneSolution.com

synopsis: Pethealth Inc. is pleased to announce that it has acquired HumaneSolution.com, a web-based data management system for clinics operated by animal welfare organizations in the US and Canada which offer spay/neuter and wellness services to the public and other AWOs.
buyer parent: Fairfax Financial Holdings Ltd.
buyer: Pethealth Inc.
Pethealth Inc. is North America’s second largest provider of medical insurance for dogs and cats to pet owners operating in Canada, the United States and the United Kingdom. They also provide management software to North American animal welfare organizations through its cloud-based application. "
target: HumaneSolution.com
HumaneSolution.com is a web-based data management system for clinics operated by animal welfare organizations (AWOs) in the US and Canada which offer spay/neuter and wellness services to the public and other AWOs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/26/2009 via Company Press Release

IDBS, will acquire InforSense Ltd.

synopsis: IDBS, a leading provider of innovative data management solutions to multinational R&D organizations, announced that it has concluded an unconditional agreement to acquire InforSense Ltd, a company providing award-winning scientific and business intelligence (BI) technologies, in an all-cash transaction.
buyer: IDBS
IDBS is a trusted provider of integrated data management software and service solutions to both the life science and non-life science industries. "
target: InforSense Ltd.
InforSense delivers fast answers to complex questions in business, healthcare and life science. InforSense's next generation business and scientific intelligence solutions provide ROI in days, not months.
price ($mm)
$8.25
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/26/2020 via BusinessWire

Dotmatics, will acquire BioBright LLC

synopsis: UK-based Dotmatics Ltd., a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery, and innovation research, will acquire BioBright LLC, a leader in automating the flow of data from laboratory instruments to a secure cloud.
buyer parent: Scottish Equity Partners
buyer: Dotmatics
UK-based Dotmatics is a scientific informatics software and services company that is driving the automation of laboratory workflows for discovery and innovation research—accelerating the journey towards full digitalization and the Lab of the Future. "
target: BioBright LLC
BioBright's mission is to revolutionize the way biological research is done by building tools that augment the scientist. The company's DarwinSync platform automatically uploads scientific data from any instrument and makes it available for search, analysis, and discovery.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/26/2020 via BusinessWire

Dotmatics, will acquire BioBright LLC

synopsis: UK-based Dotmatics Ltd., a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery, and innovation research, will acquire BioBright LLC, a leader in automating the flow of data from laboratory instruments to a secure cloud.
buyer parent: Scottish Equity Partners
buyer: Dotmatics
UK-based Dotmatics is a scientific informatics software and services company that is driving the automation of laboratory workflows for discovery and innovation research—accelerating the journey towards full digitalization and the Lab of the Future. "
target: BioBright LLC
BioBright's mission is to revolutionize the way biological research is done by building tools that augment the scientist. The company's DarwinSync platform automatically uploads scientific data from any instrument and makes it available for search, analysis, and discovery.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/5/2016 via BNC Analysis

bioMérieux S.A., acquired Applied Maths

synopsis: bioMérieux, a world leader in the field of in vitro diagnostics, announced the acquisition of Applied Maths, a company that develops state-of-the-art software solutions for the biosciences, in particular for databasing, analysis and interpretation of complex biological data.
buyer: bioMérieux S.A. (ENXTPA:BIM:$1,996.55)
A world leader in the field of in vitro diagnostics for 50 years, bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. "
target: Applied Maths
Applied Maths develops cutting-edge software for the biosciences. The company has gained worldwide recognition with its software GelCompar for the analysis of 1D gel patterns, and later even more with BioNumerics, a software suite for integrated databasing and analysis of biological data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/28/2013 via Company Press Release

Illumina, Inc., acquired NextBio, Inc.

synopsis: Illumina, Inc. has acquired Santa Clara-based NextBio, a leader in clinical and genomic informatics. NextBio is the provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. They provide innovative sequencing and array-based solutions. "
target: NextBio, Inc.
NextBio is the provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data. NextBio is delivered as a SaaS (Software as a Service) solution resulting in quick deployment and rapid return on investment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/12/2018 via BusinessWire

Medidata Solutions Worldwide, will acquire SHYFT Analytics

synopsis: Medidata announced that it has entered into a definitive agreement to acquire SHYFT Analytics, bringing the leading platform for clinical development together with the leading platform for commercial and real-world data analytics.
buyer: Medidata Solutions Worldwide (MDSO:$660.00)
Medidata's unified platform, pioneering analytics, and unrivaled expertise power the development of new therapies for over 1,000 pharmaceutical companies, biotech, medical device firms, academic medical centers and contract research organizations around the world. "
target: SHYFT Analytics
SHYFT Analytics is the leading cloud data analytics platform for life sciences with solutions designed exclusively for the pharmaceutical and biotech industry.
price ($mm)
$195
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/14/2019 via PR Newswire

GraphPad Software, Inc., acquired SnapGene

synopsis: GraphPad Software, the leading provider of software developed exclusively for the scientific community, announced it has acquired SnapGene, a leading bioinformatics software solution that provides a simple yet powerful way for researchers to plan, visualize, document, and share their everyday molecular biology procedures.
buyer: GraphPad Software, Inc.
GraphPad is the leading provider of software developed exclusively for the scientific community. GraphPad Prism, their flagship product, is the preferred analysis and graphing solution for scientific research. Prism helps scientists discover and share the story in their data. "
target: SnapGene
SnapGene was founded by scientists and software designers to meet the everyday needs of molecular biologists. Their software provides a simple yet powerful way for researchers to plan, visualize, document, and share their everyday molecular biology procedures.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/5/2011 via BusinessWire

PerkinElmer, Inc., acquired Geospiza

synopsis: PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, announced that it has acquired Geospiza, Inc., a leading developer of software systems for the management of genetic analysis and laboratory workflows delivered through a Web-based secure cloud computing environment.
buyer: PerkinElmer, Inc. (PKI:$2,209.40)
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. It designs, manufactures and delivers advanced technology solutions that address the world's most critical health and safety concerns. "
target: Geospiza
Designed by biologists for biologists, Geospiza is the developer of GeneSifter® software, providing integrated solutions for Next Generation Sequencing analysis and LIMS. Geospiza has set the industry standard for high value, low cost, “out of the box” solutions serving the life sciences market.
price ($mm)
$13
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/5/2019 via PR Newswire

Beckman Coulter, Inc, acquired Cytobank

synopsis: Beckman Coulter, a company that is advancing healthcare to enhance the diagnostic laboratory’s role in improving healthcare outcomes, announced its acquisition of Cytobank, a cloud-based analysis platform utilizing machine learning algorithms for collaborative biomedical research.
buyer parent: Danaher Corporation
buyer: Beckman Coulter, Inc (BEC:$0.00)
Beckman Coulter is committed to advancing healthcare by applying science, technology and the creativity of their teams to enhance the diagnostic laboratory’s role in improving healthcare outcomes. Their diagnostic systems are used in complex biomedical testing and are found around the globe. "
target: Cytobank
Cytobank Inc. is a cloud-based analysis platform utilizing machine learning algorithms for collaborative biomedical research. Pharmaceutical, biotechnology, and academic researchers around the world use their SaaS solution to develop deep understandings of complex biology at the single cell level.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/26/2005 via PR Newswire

Entelos Inc., acquired Discovery Innovations, Inc.

synopsis: Entelos, Inc., the leader in biosimulation technologies for pharmaceutical research and development, announced today the acquisition of Discovery Innovations, a specialized provider of data integration products and services to the life sciences.
buyer: Entelos Inc.
Entelos partners with pharmaceutical and biotech organizations worldwide to develop effective new treatments for disease and dramatically reduce the time and cost needed to develop them. Using our patented PhysioLab technology, Entelos develops dynamic large-scale computer models of human disease. "
target: Discovery Innovations, Inc.
Discovery Innovations is a specialized provider of web-based products and information services to the life sciences. Recognizing the tidal wave of information being generated in the life sciences, Discovery Innovations has developed products and services that more efficiently access, deliver and sha
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/11/2019 via PR Newswire

InVitae, will acquire Jungla Inc.

synopsis: Invitae, a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare, will acquire Jungla, an artificial intelligence driven biotechnology company utilizing computational and cellular modeling to improve clinical genetic tests.
buyer: InVitae (NVTA:$216.82)
Invitae is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare. They aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. "
target: Jungla Inc.
Jungla Inc. is an artificial intelligence driven biotechnology company utilizing computational and cellular modeling to improve clinical genetic tests. Jungla's technologies combine advances in functional genomics, computational biophysics, cellular engineering, and computer science.
price ($mm)
$50
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/12/2014 via Company Press Release

Wiley, acquired SimBioSys Inc.

synopsis: John Wiley & Sons, Inc., a global provider of knowledge and knowledge-enabled solutions that improve outcomes in research, professional practice, and education, announced that it has acquired SimBioSys Inc., a provider of scientific software tools that facilitate the drug discovery process.
buyer: Wiley (NYSE:JW.A:$1,848.05)
Wiley is a global provider of knowledge and knowledge-enabled services that improve outcomes in areas of research, professional practice, and education. "
target: SimBioSys Inc.
SimBioSys is a recognized leader in the field of rational drug discovery software. Providing a wide range of software solutions, the company is focused on the development of scientific tools to facilitate the drug discovery process.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/24/2011 via BusinessWire

PerkinElmer, Inc., will acquire CambridgeSoft Corporation

synopsis: PerkinElmer, Inc. has announced that it has signed a definitive agreement to acquire CambridgeSoft Corporation, a leading supplier of discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases and professional services to the pharmaceutical, biotechnology, and chemical industries.
buyer: PerkinElmer, Inc. (PKI:$2,209.40)
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. It designs, manufactures and delivers advanced technology solutions that address the world's most critical health and safety concerns. "
target parent: Health Evolution Partners LLc
target: CambridgeSoft Corporation
CambridgeSoft Corporation is a leading supplier of discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases and professional services to the pharmaceutical, biotechnology, and chemical industries.
price ($mm)
$227
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/10/2016 via PR Newswire

Sunquest Information Systems, acquired UNIConnect LC

synopsis: Provider of diagnostics informatics solutions to more than 1,700 laboratories, Sunquest Information Systems, Inc. announced the acquisition of the Salt Lake City-based software firm UNIConnect® L.C. UNIConnect specializes in software for molecular laboratories and augments Sunquest's molecular diagnostics solution.
buyer parent: Roper Technologies, Inc.
buyer: Sunquest Information Systems
Sunquest Information Systems Inc. provides diagnostics informatics solutions to more than 1,700 laboratories. Since 1979, Sunquest has helped laboratories and healthcare organizations across the world optimize financial results, enhance efficiency and improve the quality of patient care. "
target: UNIConnect LC
Based in Salt Lake City, UT, UNIConnect® L.C. has created a Laboratory Information Management System (LIMS) platform that marries breakthrough software technology with unparalleled customization and configuration control to advance the "omic" sciences and precision medicine.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/2/2015 via PR Newswire

Tute Genomics, acquired Knome, Inc.

synopsis: Tute Genomics, the leader in clinical sequencing infomatics, announced its acquisition of key assets of Knome, a renowned human-genome interpretation company whose systems and services helped spearhead several of the greatest commericial advancements in modern human genetics.
buyer: Tute Genomics
Tute Genomics provides a cloud-based genome informatics solution to help diagnostic labs and health systems process next-generation sequencing data in a secure fashion. Tute is powering the world's genomic knowledge through enterprise informatics, genome interpretation, and clinical insights. "
target: Knome, Inc.
Knome, Inc. is a leading provider of human genome interpretation systems and services. Knome provides tools and solutions that help researchers, drug developers, and clinicians determine the genetic basis of human disease and drug response.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like BioBright LLC


read more

BioBright LLC

Arxspan

FactBio Ltd

Infonetica ltd.

Linguamatics Limited

M2S

Healthcare Data Services LLC

Cunesoft

Zephyr Health

Recombinant Data Corp.

Core Informatics LLC

BoundaryMedical, Inc.

TrialStat Corporation

Analytics Partners

Ivbar

Docufill, LLC

BetterDoctor, Inc.

Aries Systems Corp.

HumaneSolution.com

InforSense Ltd.

read more

BioBright LLC

read more

BioBright LLC

read more

Applied Maths

NextBio, Inc.

SHYFT Analytics

SnapGene

Geospiza

Cytobank

Discovery Innovations, Inc.

Jungla Inc.

SimBioSys Inc.

CambridgeSoft Corporation

UNIConnect LC

Knome, Inc.

Geography
Matching Companies
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: TSXV:NGH
 
 
 
 
 
 
 
 
Nightingale Informatix Corporation
Nightingale Informatix Corporation
For more than a decade, Nightingale has been delivering innovative cloud-based Electronic Health Record and Practice Management solutions to healthcare organizations across the United States and Canada. They create software that is truly intuitive—minimizing training and maximizing adoption.
year
2015
rev ($mm)
$9.64
EBITDA ($mm)
($1.47)
EBIT ($mm)
($2.00)
Net Income ($mm)
$1.47
Employees
120
  • drill down
  • watch
Ticker: VEEV
 
 
 
 
 
 
 
 
Veeva Systems
Veeva Systems
Veeva Systems is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence and customer success, Veeva has over 300 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs.
year
2019
rev ($mm)
$968.71
EBITDA ($mm)
$289.09
EBIT ($mm)
$271.12
Net Income ($mm)
$287.93
Employees
2553
  • drill down
  • watch
Ticker: MODN
 
 
 
 
 
 
 
 
Model N, Inc.
Model N, Inc.
Model N is the pioneer and leading provider of Revenue Management cloud solutions for the Life Sciences and High Technology industries. Model N helps its customers maximize their revenues by maximizing sell time, revenues per opportunity and number of opportunities.
year
2016
rev ($mm)
$106.97
EBITDA ($mm)
($26.81)
EBIT ($mm)
($32.74)
Net Income ($mm)
Employees
814
  • drill down
  • watch
Ticker: ASX:CGL
 
 
 
 
 
 
 
 
Citadel Group Limited
Citadel Group Limited
Citadel is a leading Australian technology and software company that specialise in secure enterprise information management in complex environments. Citadel provides secure information to support real-time decisions across the Health, National Security and Defence industries.
year
2019
rev ($mm)
$73.75
EBITDA ($mm)
$10.86
EBIT ($mm)
$8.04
Net Income ($mm)
$4.10
Employees
180
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch